Meghann Smith has been appointed senior director of Global Therapeutic Strategic Development within the OckhamCRO division. Ms. Smith will provide clients and functional teams with strategic guidance, risk mitigation analysis and solutions throughout the life cycle of projects. She has more than 20 years of clinical and research expertise in a variety of therapeutic indications. Ms. Smith’s primary therapeutic focus is in hematology and oncology, with experience in multiple indications includin...